Browsing by Title

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 12642 to 12661 of 47147 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Platelet aggregatory response to platelet activating factor (PAF), ex vivo, and PAF-acetylhydrolase activity in patients with unstable angina: effect of c7E3 Fab (abciximab) therapyTselepis, A. D.; Goudevenos, J. A.; Tambaki, A. P.; Michalis, L.; Stroumbis, C. S.; Tsoukatos, D. C.; Elisaf, M.; Sideris, D. A.24-Nov-2015-
Platelet derived microparticles inhibit Cu2+-induced LDL oxidationMitsios, J. V.; Lourida, E. S.; Papavasiliou, E. C.; Tselepis, A. D.24-Nov-2015-
Platelet function and lipid-lowering interventionsMilionis, H. J.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
The platelet function modification by chemical carcinogenesis inhibitorsKarkabounas, S.; Karabetsos, D.; Gogos, C.; Beka, A.; Evangelou, A.24-Nov-2015-
Platelet glycoprotein IIb HPA-3 polymorphism and acute coronary syndromesLekakis, J.; Bisti, S.; Tsougos, E.; Papathanassiou, A.; Dagres, N.; Ikonomidis, I.; Soteriadou, E.; Tselepis, A. D.; Goudevenos, J.; Kremastinos, D. T.24-Nov-2015-
Platelet hyperaggregability to platelet activating factor (PAF) in non-ST elevation acute coronary syndromesMichalis, L. K.; Tambaki, A. P.; Katsouras, C. S.; Goudevenos, J. A.; Kolettis, T.; Adamidis, K.; Tselepis, A. D.; Sideris, D. A.24-Nov-2015-
The platelet hyporesponsiveness to clopidogrel in acute coronary syndrome patients treated with 75 mg/day clopidogrel may be overcome within 1 month of treatmentKalantzi, K. I.; Dimitriou, A. A.; Goudevenos, J. A.; Tselepis, A. D.24-Nov-2015-
Platelet response to the aggregatory effect of platelet activating factor (PAF) ex vivo in patients with acute myocardial infarctionTselepis, A. D.; Tsoukatos, D.; Droudes, C.; Donas, A.; Evangelou, A.24-Nov-2015-
Platelet Response to the Aggregatory Effect of Platelet-Activating-Factor (Paf) Exvivo in Patients with Acute Myocardial-InfarctionTselepis, A. D.; Tsoukatos, D.; Droudes, C.; Donas, A.; Evangelou, A.24-Nov-2015-
Platelet-activating factor (PAF) and PAF-acetylhydrolase activity are secreted from human platelets mainly associated with platelet derived microparticlesMitsios, J. V.; Tsironis, L. D.; Tselepis, A. D.24-Nov-2015-
Platelet-Activating Factor (Paf) Bioactivity Formation and Lyso-Paf Accumulation in Human ArteriesTsoukatos, D. C.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Brocheriou, I.; Ninio, E.; Sismanidis, S.; Siminelakis, S.24-Nov-2015-
Platelet-activating factor acetylhydrolase and acute respiratory distress syndrome: unanswered questionsNakos, G.; Tsangaris, I.; Lekka, M. E.24-Nov-2015-
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary arteryTsoukatos, D. C.; Brocheriou, I.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Ninio, E.; Siminelakis, S.24-Nov-2015-
Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoproteinTsoukatos, D. C.; Liapikos, T. A.; Tselepis, A. D.; Chapman, M. J.; Ninio, E.24-Nov-2015-
Platelet-activating factor and oxidized LDLAndroulakis, N.; Aronis, P.; Tsoukatos, D. C.24-Nov-2015-
Platelet-activating factor bio-system in human arteriesTsoukatos, D. C.; Brocheriou, I.; Ninio, E.; Moussis, V.; Panopoulou, C. P.; Christofidou, E. D.; Koussissis, S.; Sismanidis, S.; Siminelakis, S.24-Nov-2015-
Platelet-Activating-Factor Formation during Oxidative Modification of Low-Density-Lipoprotein When Paf-Acetylhydrolase Has Been InactivatedLiapikos, T. A.; Antonopoulou, S.; Karabina, S. A. P.; Tsoukatos, D. C.; Demopoulos, C. A.; Tselepis, A. D.24-Nov-2015-
Platelet-associated and secreted PAF-acetylhydrolase activity in patients with stable angina: sequential changes of the enzyme activity after angioplastyGoudevenos, J.; Tselepis, A. D.; Vini, M. P.; Michalis, L.; Tsoukatos, D. C.; Elisaf, M.; Ninio, E.; Sideris, D. A.24-Nov-2015-
Platelet-derived microparticles inhibit the oxidative modification of LDL possibly through their phosphatidylserine and plasmalogen contentMitsios, J. V.; Tsironis, L. D.; Dimitriou, A. A.; Tselepis, A. D.24-Nov-2015-
Platelet-Mediated Inflammation in Cardiovascular Disease. Potential Role of Platelet-Endothelium InteractionsTsoumani, M. E.; Kalantzi, K. I.; Goudevenos, I. A.; Tselepis, A. D.24-Nov-2015-